I sold this morning before the big drop (still took a hit of about $450). I read about this company Amarin this morning that did some good shyt with Fish Oil to combat Heart Disease. I sold off NBEV and 100 shares of AMD and got in AMRN at $9s. Its closed at $12.40 today. Right after I bought, it went up $10 and started receiving price targets of $50!
Good read for those interested:
REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules Met Primary Endpoint | Amarin Corporation plc
Some where expecting buyout offers of $50 a share when I bought this morning. Now, some are mention buyout offers of $80-$100.
Hopefully, I can add close to 100 shares Friday.
The rally in Amarin stock is far from over. The company has a $3 billion market cap now on $230 million in projected sales this year. That seems rich. But, the cardiovascular health market measures $500 billion in the U.S. alone, and ARMN just unlocked the code to tap into a big portion of that market. Plus, the company doesn’t have much competition because they are the only ones with positive data.
From this perspective, a $3 billion market cap for a company tapping into a $500 billion industry doesn’t seem all that big. That is why I think Amarin stock can still go higher. Much higher, actually.
Yahoo is now part of Oath